Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis

Brown, 2017, Amyotrophic lateral sclerosis, N. Engl. J. Med., 377, 162, 10.1056/NEJMra1603471 Kaur, 2008, Antioxidants and neuroprotection in the adult and developing central nervous system, Curr. Med. Chem., 15, 3068, 10.2174/092986708786848640 Beal, 1997, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann. Neurol., 42, 644, 10.1002/ana.410420416 Tohgi, 1999, Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis, Ann. Neurol., 46, 129, 10.1002/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y Ikawa, 2015, Increased oxidative stress is related to disease severity in the ALS motor cortex: a PET study, Neurology, 84, 2033, 10.1212/WNL.0000000000001588 Fujisawa, 2016, Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone, Redox Rep., 21, 98, 10.1179/1351000215Y.0000000025 Yoshino, 2006, Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (phase II study), Amyotroph. Lateral Scler., 7, 241, 10.1080/17482960600881870 Abe, 2014, Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients, Amyotroph Lateral Scler. Frontotemporal. Degener., 15, 610, 10.3109/21678421.2014.959024 Writing, 2017, Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial, Lancet Neurol., 16, 505, 10.1016/S1474-4422(17)30115-1 Brooks, 2000, World Federation of Neurology Research Group on motor neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Other Motor Neuron Disord, 1, 293, 10.1080/146608200300079536 Tetsuka, 2013, Utility of cystatin C for renal function in amyotrophic lateral sclerosis, Acta Neurol. Scand., 128, 386, 10.1111/ane.12134 2017, Amyotroph. Lateral Scler. Frontotemporal Degener., 18, 55, 10.1080/21678421.2017.1364269 Fogh, 2016, Association of a Locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis, JAMA Neurol, 73, 812, 10.1001/jamaneurol.2016.1114 Traynor, 2003, Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000, J. Neurol. Neurosurg. Psychiatry, 74, 1258, 10.1136/jnnp.74.9.1258